PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.84%
Some net income increase while MCHP is negative at -39.37%. John Neff would see a short-term edge over the struggling competitor.
13.44%
Some D&A expansion while MCHP is negative at -0.58%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
42.53%
Some yoy growth while MCHP is negative at -413.58%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-100.00%
Negative yoy SBC while MCHP is 5.23%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
100.69%
Slight usage while MCHP is negative at -200.00%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
47.52%
AR growth well above MCHP's 7.52%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
21.88%
Some inventory rise while MCHP is negative at -398.91%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
176.03%
A yoy AP increase while MCHP is negative at -242.48%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
137.09%
Lower 'other working capital' growth vs. MCHP's 1225.35%. David Dodd would see fewer unexpected short-term demands on cash.
318.64%
Some yoy increase while MCHP is negative at -150.31%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
119.08%
Some CFO growth while MCHP is negative at -88.44%. John Neff would note a short-term liquidity lead over the competitor.
-16.21%
Negative yoy CapEx while MCHP is 125.40%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-84.23%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
-98.97%
Both yoy lines negative, with MCHP at -96200.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-206.54%
We reduce yoy invests while MCHP stands at 48.84%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
259.87%
Debt repayment similar to MCHP's 245.03%. Walter Schloss sees parallel liability management or similar free cash flow availability.
-2.54%
Negative yoy issuance while MCHP is 56.49%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
53.75%
Buyback growth at 50-75% of MCHP's 76.20%. Martin Whitman questions partial disadvantage in per-share enhancements if competitor repurchases more.